{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:29:24Z","timestamp":1790026164392,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.atherosclerosis.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T06:49:35Z","timestamp":1465714175000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis"],"prefix":"10.1016","volume":"251","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4920-623X","authenticated-orcid":false,"given":"Rupert W.","family":"Major","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaam","family":"Oozeerally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Riddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Brunskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.06.013_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic kidney disease management in the United Kingdom: NEOERICA project results","volume":"72","author":"Stevens","year":"2007","journal-title":"Kidney Int."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2016.06.013_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.06.013_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","article-title":"Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis","volume":"121","author":"Berger","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib4","series-title":"Type 2 Diabetes: the Management of Type 2 Diabetes","year":"2009"},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","volume":"121","author":"Pignone","year":"2010","journal-title":"Circulation"},{"issue":"9678","key":"10.1016\/j.atherosclerosis.2016.06.013_bib6","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib7","series-title":"Chronic Kidney Disease: Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib8","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib9","series-title":"Identifier NCT01709994","year":"2015"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2016.06.013_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.06.013_bib11","doi-asserted-by":"crossref","first-page":"e104179","DOI":"10.1371\/journal.pone.0104179","article-title":"Low-Dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.06.013_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"suppl 2","key":"10.1016\/j.atherosclerosis.2016.06.013_bib13","article-title":"Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR< 45 ml\/min)","volume":"30","author":"Bilo","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib14","unstructured":"Crd.york.ac.uk. PROSPERO - International prospective register of systematic reviews [Internet]. 2015 [cited 13 October 2015]. Available from: http:\/\/www.crd.york.ac.uk\/PROSPERO\/."},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib15","series-title":"Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0","year":"2011"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.06.013_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom heart and renal protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.06.013_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc10-1615","article-title":"Low-Dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate subanalysis from the JPAD trial","volume":"34","author":"Saito","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"Modification of Diet in Renal Disease Study Group: a more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.06.013_bib20","first-page":"94","article-title":"Uremic bleeding: pathogenesis and therapy","volume":"316","author":"Weigert","year":"1998","journal-title":"Am. J. Med. Sci."},{"issue":"43","key":"10.1016\/j.atherosclerosis.2016.06.013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17430","article-title":"Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews","volume":"17","author":"Sutcliffe","year":"2013","journal-title":"Health Technol. Assess."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.06.013_bib22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","article-title":"Risk prediction models for patients with chronic kidney disease: a systematic review","volume":"158","author":"Tangri","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.06.013_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham predictive instrument in chronic kidney disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9844","key":"10.1016\/j.atherosclerosis.2016.06.013_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"9854","key":"10.1016\/j.atherosclerosis.2016.06.013_bib25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"issue":"9854","key":"10.1016\/j.atherosclerosis.2016.06.013_bib26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.06.013_bib27","article-title":"Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials","author":"Kunutsor","year":"2016","journal-title":"Diabet. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T13:33:40Z","timestamp":1531402420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016302581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":27,"alternative-id":["S0021915016302581"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}